Stella currently works as a lawyer in Milan. She is so busy with her many challenging jobs and his busy schedule that it is difficult for him to pay attention to the follow-up of her therapy. As long as Stella is (or has been) adhering to treatment, her condition appears stable. However, a promotion at work and the associated stress had a negative effect on his condition. Several studies have reported that patients who adhere to regimens tend to remain in remission longer than those with low adherence.
Patients with UC have approximately 50% non-compliance during long-term therapy. All this increases the risk of clinical relapse. Patient adherence to the physician-recommended therapeutic regimen, especially in the long term, has long been a common problem in medical practice.
The frequency of medication is an important part of treatment adherence. On average, UC patients who do not have relapses or remission take only 70% or less of their prescribed medication. Self-medication, forgetfulness, side effects, costs, pill size and dosing frequency also play a role.
Simplified drug dosing schedules (e.g. once-daily drug intake) result in better collaboration and better adherence to treatment. They are therefore considered an important advantage in the treatment of UC patients.
After talking to the gastroenterologist, Stella became more motivated, avoiding another flare-up of the disease. To make it easier to take medicines, he was prescribed a preparation to be administered once a day.
Do you like what you see? Share with a friend.